Home/NexEos Bio/Gerald Gleich, MD

GG

Gerald Gleich, MD

Scientific Founder and Chief Scientific Officer

Therapeutic Areas

Ophthalmology Gastroenterology Immunology/Allergy

NexEos Bio Pipeline

Drug	Indication	Phase
NTX-1024	Vernal Keratoconjunctivitis (VKC) / Allergic Conjunctivitis	Phase 2
NDX-3324	Eosinophilic Esophagitis (EoE) - Diagnostic	Clinical

Leadership Team at NexEos Bio

Stephen Tullman

Co-Founder, Executive Chairman, and Chief Executive Officer

Chief Business Officer

View full NexEos Bio profile